Exercise capacity in patients implanted with left ventricular assist devices for end-stage heart failure treatment

15 April 2021 (08:00 - 19:20)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Julian Oesterschlink

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

334 More presentations in this session

Presentation thumbnail

A diet-related microsimulation modelling approach in the context of cardiovascular disease prevention: the ATTICA and GREECS epidemiological studies.

Professor D. Panagiotakos (Athens, GR)

Abstract Slides

Presentation thumbnail

s-VCAM-1 is an independent predictor of all-cause mortality in patients with dilated cardiomyopathy and hypokinetic non-dilated cardiomyopathy

Doctor K. Lehnert (Greifswald, DE)

Abstract Slides

Presentation thumbnail

Age-standardized prevalence of social determinants of health and associated race-ethnic disparities in stroke survivors

Doctor T. Parekh (Newark, US)

Abstract Slides

Presentation thumbnail

Impact of Proteinuria and Low eGFR on Lifetime Risk of Cardiovascular Disease Death: A Pooled Analysis of Data From the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Study

Ms Y. Imai (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Risk of cerebrovascular accidents according to weather and pollution features

Associate Professor G. Biondi-Zoccai (Latina, IT)

Abstract Slides

Access the full session

Session thumbnail

ePosters

The Event

ESC Preventive Cardiology 2021

15 April 2021 08:00 CET

You may be interested in

Congress Session

Navigating through heart failure device therapies

Congress Session

Which device might help your HFpEF patient?

Congress Session

Devices in acute heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources